Table S4: Questions, potential answers, and results of survey 1 and the answers that were qualified for the second Delphi round (survey 2) according to the study criteria
Stanton McHardy and Hua-Yu Leo Wang) at the Center for Innovative Drug Discovery, University of Texas San Antonio for the synthesis and supply of scaled batches of 5-amino-1-methylquinolinium
Sourcing from Canadian vendors with verified third-party testing, proper storage, and sterile injection technique addresses the majority of practical risks
The commenter expressed concern that the specialty group would also have to identify where to place its limited resources to improve performance, deciding whether to focus on the 6 measures required to report for MIPS or the measures that are required to report for the individuals required to participate in the ASM
FDA's Official Reasons: Lack of Clinical Trials: The FDA emphasizes the need for extensive, controlled clinical trials, which are currently lacking